KAM
AGN

Krensavage Asset Management’s Allergan plc AGN Stock Holding History

Krensavage Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,416
Closed -$6.1M – 19
2016
Q2 		$6.1M Buy
26,416
+146
+0.6% +$33.7K 2.2% 15
2016
Q1 		$7.04M Sell
26,270
-124
-0.5% -$35.5K 2.53% 14
2015
Q4 		$8.25M Buy
26,394
+2,154
+9% +$641K 2.63% 14
2015
Q3 		$6.59M Buy
24,240
+950
+4% +$292K 2.39% 16
2015
Q2 		$7.07M Buy
23,290
+1,336
+6% +$398K 2.67% 16
2015
Q1 		$6.53M Sell
21,954
-1,062
-5% -$303K 2.98% 15
2014
Q4 		$5.92M Buy
+23,016
New +$5.75M 3.3% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Krensavage Asset Management's AGN Position: Q3 2016 in Review

Krensavage Asset Management sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 26,416 shares — an estimated $6.1M sold.

Krensavage Asset Management first reported a position in AGN in Q4 2014 and held it in 7 quarters. The position peaked at $8.25M in Q4 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Krensavage Asset Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Krensavage Asset Management sold 26,416 Allergan plc shares in Q3 2016, an estimated $6.1M.
  • Krensavage Asset Management first reported a position in Allergan plc in Q4 2014 and held it in 7 quarters.
  • Krensavage Asset Management's Allergan plc position peaked at $8.25M in Q4 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Krensavage Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.